🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

reproxalap

Aldeyra Therapeutics, Inc. is a biotechnology company that develops and commercializes medicines for immune-mediated ocular and systemic diseases, with lead product candidate reproxalap in Phase III clinical trials.

Tags: biotechnology, clinical trials, immune-mediated diseases, ocular diseases, systemic diseases

Website

Leadership | About | Contact | Careers | About | About | About

Symbol: ALDX

Recent Price: $5.02

Industry: Biotechnology

CEO: Dr. Todd C. Brady M.D., Ph.D.

Sector: Healthcare

Employees: 10

Address: 131 Hartwell Avenue, Lexington, MA 02421

Phone: 781 761 4904

Leadership

  • Todd C. Brady, M.D., Ph.D., Chief Executive Officer, President & Director
  • Stephen G. Machatha, Ph.D., Chief Development Officer
  • Caitlin Pazzano, Vice President, Quality Assurance
  • Bill Cavanagh, Vice President, Clinical Operations
  • Neal Walker, D.O., Director
  • Gary Phillips, M.D., M.B.A., Director
  • Nancy Miller-Rich, Director
  • Martin J. Joyce, M.B.A., Director
  • Ben Bronstein, M.D., Director
  • Richard H. Douglas, Ph.D., Chairman of the Board

Last updated: 2024-12-31